(Q67802041)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760862%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Local treatment of cutaneous and subcutaneous metastatic malignant melanoma with fotemustine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760862%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

author name string

K U Schallreuter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760862%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

J M Wood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760862%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

H Mensing

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760862%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

E W Breitbart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760862%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760862%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

17 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760862%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760862%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760862%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

167-171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760862%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00687330

17 September 2019

exact match

0 references

cites work

Phase I clinical study of the new amino acid-linked nitrosourea, S 10036, administered on a weekly schedule

1 reference

12 December 2020

Positive phase II study in the treatment of advanced malignant melanoma with fotemustine

1 reference

12 December 2020

Disposition, pharmacokinetics, and metabolism of 14C-fotemustine in cancer patients

1 reference

12 December 2020

Sensitivity and resistance in human metastatic melanoma to the new chloroethylnitrosourea anti-tumor drug Fotemustine

1 reference

12 December 2020

The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00687330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760862%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference